JPMorgan Chase & Co. Lowers Clorox (NYSE:CLX) Price Target to $114.00

Clorox (NYSE:CLX) had its price objective lowered by investment analysts at JPMorgan Chase & Co. from $120.00 to $114.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 3.68% from the company’s current price.

A number of other research firms have also issued reports on CLX. Citigroup dropped their target price on Clorox from $120.00 to $109.00 and set a “neutral” rating on the stock in a report on Wednesday, December 17th. BNP Paribas Exane dropped their price objective on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Clorox from $128.00 to $121.00 and set a “hold” rating for the company in a research note on Tuesday, November 4th. Bank of America lowered their target price on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Finally, TD Cowen cut their price target on shares of Clorox from $117.00 to $108.00 and set a “hold” rating for the company in a report on Thursday, January 8th. One investment analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average target price of $122.19.

Clorox Trading Down 1.2%

Shares of Clorox stock opened at $109.95 on Friday. The company’s fifty day moving average is $103.13 and its two-hundred day moving average is $115.26. Clorox has a 1 year low of $96.66 and a 1 year high of $164.22. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76. The company has a market capitalization of $13.41 billion, a P/E ratio of 17.26, a PEG ratio of 0.54 and a beta of 0.58.

Clorox (NYSE:CLX) last announced its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.07. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business’s quarterly revenue was down 18.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts forecast that Clorox will post 7.15 earnings per share for the current year.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The stock was bought at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the transaction, the director owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

Hedge funds have recently bought and sold shares of the company. Brown Lisle Cummings Inc. grew its holdings in Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares during the last quarter. American National Bank & Trust grew its stake in Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares during the last quarter. Savvy Advisors Inc. grew its stake in Clorox by 1.4% in the 2nd quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after acquiring an additional 91 shares during the last quarter. Canandaigua National Bank & Trust Co. raised its position in Clorox by 0.8% during the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after acquiring an additional 94 shares during the last quarter. Finally, State of Michigan Retirement System increased its stake in shares of Clorox by 0.3% during the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after purchasing an additional 100 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.